Jaguar Health (NASDAQ:JAGX) Share Price Passes Above 50-Day Moving Average – Time to Sell?

Shares of Jaguar Health, Inc. (NASDAQ:JAGX) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.02 and traded as high as $1.20. Jaguar Health shares last traded at $1.09, with a volume of 425,377 shares traded.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Jaguar Health from a “sell” rating to a “hold” rating in a research note on Friday, September 13th.

Jaguar Health Stock Performance

The business has a 50 day simple moving average of $1.02 and a 200 day simple moving average of $1.52. The company has a debt-to-equity ratio of 1.65, a quick ratio of 1.36 and a current ratio of 1.84.

Hedge Funds Weigh In On Jaguar Health

A hedge fund recently bought a new stake in Jaguar Health stock. Virtu Financial LLC purchased a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health at the end of the most recent reporting period. 12.04% of the stock is owned by institutional investors and hedge funds.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.